Skip to main content
Home
  • Het APPROACH-project
  • Le projet APPROACH
  • APPROACH-prosjektet
  • El proyecto APPROACH
  • My Project Plaza
  • Home
  • About
    • About
    • About the project
    • Why osteoarthritis?
    • Project deliverables
    • Results and Publications
    • Work packages
    • Governance
  • Patient Engagement
    • Patient Engagement
    • Patient Council
    • Participant Newsletters
    • Participant Brochures
  • Partners
  • Newsroom
    • Publications
  • Contact

Search form

Open Close
HomePartners

Partners

The APPROACH project brings together a strong team of 22 partners from European clinical centres, basic research institutes, small and medium-sized enterprises and pharmaceutical companies. 
https://www.gsk.com/
http://www.umcutrecht.nl/
https://www.lumc.nl/
http://www.lygature.org
http://www.lunduniversity.lu.se/
http://www.ncl.ac.uk/
https://www.fau.de/
https://www.uk-erlangen.de
http://www.artialis.com/
http://www.reumafonds.nl/
http://www.inibic.es/
http://www.aphp.fr/
http://www.diakonhjemmet.no/
http://www.idsplc.com/
http://www.etb.uk.com/
http://www.servier.com/
http://biopharma.merckgroup.com/
http://www.nordicbioscience.com/
http://www.cnrs.fr/
https://www.leeds.ac.uk/
https://www.versusarthritis.org/
https://www.oulu.fi/university/

Stay connected

Twitter

© Copyright IMI APPROACH and its partners   |   Terms and Conditions   |   Privacy Policy   |   Cookies Policy   |   Copyright   |   Disclaimer   

The research leading to these results has received support from the Innovative Medicines Initiative Joint Undertaking under grant Agreement n° 115770, resources of which are composed of financial contribution from the European Union's Seventh Framework Programme (FP7/2007-2013) and EFPIA companies’ in kind contribution. See IMI Europe.

Close

Approach Newsletter